Skip to content
PICO Portalanswers from OpenAlex

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study

PaperCitations, authors & open-access status

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is a paper indexed in PICO Portal from OpenAlex.

How many citations does Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study have?

PICO Portalcitation count

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study has 5 citations in the OpenAlex counts PICO Portal stores.

When was Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study published?

PICO Portalyear

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study has 2024 year in the PICO Portal index.

What is the open-access status of Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?

PICO Portaloa status

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study has bronze oa status in the PICO Portal index.

What is the DOI of Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?

PICO Portaldoi

The DOI for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is on the source record.

What is the PMID of Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?

PICO Portalpmid

The PMID for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is on the source record.

What is the OpenAlex record for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study?

PICO Portalopenalex

The OpenAlex for Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial